CaixaBank, S.A.’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $96.2M | Buy |
183,918
+11,198
| +6% | +$5.73M | 0.43% | 52 |
|
|
2026
Q2 | $85.8M | Sell |
172,720
-2,903
| -2% | -$1.29M | 0.4% | 59 |
|
|
2026
Q1 | $78.4M | Sell |
175,623
-15,895
| -8% | -$7.41M | 0.42% | 55 |
|
|
2025
Q4 | $86.8M | Buy |
191,518
+491
| +0.3% | +$212K | 0.43% | 53 |
|
|
2025
Q3 | $74.8M | Sell |
191,027
-70,872
| -27% | -$29.6M | 0.38% | 59 |
|
|
2025
Q2 | $117M | Buy |
261,899
+2,704
| +1% | +$1.25M | 0.6% | 44 |
|
|
2025
Q1 | $126M | Buy |
259,195
+9,108
| +4% | +$4.24M | 0.73% | 39 |
|
|
2024
Q4 | $101M | Buy |
250,087
+1,189
| +0.5% | +$551K | 0.53% | 51 |
|
|
2024
Q3 | $116M | Sell |
248,898
-2,147
| -0.9% | -$1.03M | 0.63% | 40 |
|
|
2024
Q2 | $118M | Buy |
251,045
+27,111
| +12% | +$11.8M | 0.67% | 40 |
|
|
2024
Q1 | $93.6M | Sell |
223,934
-5,156
| -2% | -$2.18M | 0.56% | 50 |
|
|
2023
Q4 | $93.2M | Sell |
229,090
-27,335
| -11% | -$10.1M | 0.64% | 45 |
|
|
2023
Q3 | $89.2M | Sell |
256,425
-2,745
| -1% | -$960K | 0.69% | 42 |
|
|
2023
Q2 | $91.2M | Sell |
259,170
-20,781
| -7% | -$7M | 0.68% | 42 |
|
|
2023
Q1 | $88.2M | Buy |
279,951
+30,660
| +12% | +$9.2M | 0.71% | 39 |
|
|
2022
Q4 | $72M | Buy |
249,291
+58,672
| +31% | +$17.9M | 0.6% | 50 |
|
|
2022
Q3 | $55.2M | Buy |
190,619
+36,558
| +24% | +$10.5M | 0.48% | 54 |
|
|
2022
Q2 | $43.4M | Buy |
154,061
+107,200
| +229% | +$28.7M | 0.39% | 67 |
|
|
2022
Q1 | $12.2M | Buy |
46,861
+1,508
| +3% | +$358K | 0.1% | 142 |
|
|
2021
Q4 | $10M | Sell |
45,353
-1,482
| -3% | -$288K | 0.08% | 179 |
|
|
2021
Q3 | $8.5M | Sell |
46,835
-2,067
| -4% | -$404K | 0.08% | 179 |
|
|
2021
Q2 | $9.9M | Sell |
48,902
-5,717
| -10% | -$1.2M | 0.09% | 150 |
|
|
2021
Q1 | $11.7M | Buy |
54,619
+4,508
| +9% | +$990K | 0.12% | 134 |
|
|
2020
Q4 | $11.8M | Buy |
50,111
+3,544
| +8% | +$813K | 0.11% | 158 |
|
|
2020
Q3 | $12.7M | Buy |
46,567
+1,386
| +3% | +$382K | 0.13% | 142 |
|
|
2020
Q2 | $13.1M | Buy |
45,181
+42,166
| +1,399% | +$11.4M | 0.16% | 128 |
|
|
2020
Q1 | $717K | Buy |
+3,015
| New | +$692K | 0.01% | 242 |
|
|
2019
Q2 | – | Sell |
-64,458
| Closed | -$11.8M | – | 383 |
|
|
2019
Q1 | $11.8M | Buy |
64,458
+57,177
| +785% | +$10.6M | 0.27% | 101 |
|
|
2018
Q4 | $1.18M | Buy |
7,281
+3,539
| +95% | +$613K | 0.03% | 196 |
|
|
2018
Q3 | $644K | Buy |
3,742
+1,165
| +45% | +$207K | 0.02% | 218 |
|
|
2018
Q2 | $438K | Buy |
2,577
+1,449
| +128% | +$225K | 0.01% | 214 |
|
|
2018
Q1 | $184K | Sell |
1,128
-10
| -0.9% | -$1.63K | 0.01% | 257 |
|
|
2017
Q4 | $171K | Sell |
1,138
-58
| -5% | -$8.59K | 0.01% | 255 |
|
|
2017
Q3 | $182K | Buy |
+1,196
| New | +$180K | 0.01% | 236 |
|
Other funds holding VRTX
CaixaBank, S.A.'s VRTX Position: Q3 2026 in Review
CaixaBank, S.A. increased its Vertex Pharmaceuticals (VRTX) stake by 6.5% in Q3 2026, buying an estimated $5.73M and bringing the position to 183,918 shares worth $96.2M. The position accounts for 0.43% of the portfolio, ranked #52.
CaixaBank, S.A. first reported a position in VRTX in Q3 2017 and has held it in 34 quarters since. The position peaked at $126M in Q1 2025. 1,798 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- CaixaBank, S.A. held 183,918 shares of Vertex Pharmaceuticals worth $96.2M as of Q3 2026.
- CaixaBank, S.A. bought 11,198 Vertex Pharmaceuticals shares in Q3 2026, an estimated $5.73M.
- Vertex Pharmaceuticals made up 0.43% of CaixaBank, S.A.'s portfolio in Q3 2026, its #52 holding.
- CaixaBank, S.A. first reported a position in Vertex Pharmaceuticals in Q3 2017 and has held it in 34 quarters since.
- CaixaBank, S.A.'s Vertex Pharmaceuticals position peaked at $126M in Q1 2025.
- 1,798 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on CaixaBank, S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.